GENERAL: AFT: interim results announcement on Thursday November 18 2021 Opens in a new Window

12 October 2021

AFT Pharmaceuticals to announce half year interim results on Thursday November 18 2021

AFT Pharmaceuticals (NZX: AFT, ASX: AFP) announced today that it intends to release on Thursday November 18 2021 its half year interim results for the period ended September 30 2021. The release will be issued at around 09:00.

This will be followed by a presentation by management at 10:00 by teleconference. The presentation material which will be referred to by management will be issued at around 09:00 and will also be available on the company's website aftpharm.com.

To attend the conference call, you will need to use the pre-registration link below. Once you have completed this you will be provided with dial in details and a unique pin code.

Registration Link:https://s1.c-conf.com/diamondpass/10016997-hgfr45.html

For and on behalf of AFT Pharmaceuticals Limited, Malcolm Tubby, CFO.

For more information:

Investors	Media
Malcolm Tubby	Richard Inder
CFO, AFT Pharmaceuticals Ltd	The Project
Phone: [phone]	Phone: [phone]
Email:[e-mail]	Email:[e-mail]

About AFT Pharmaceuticals

AFT is a growing multinational pharmaceutical company that develops, markets and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major pharmaceutical distribution channels: over-the-counter (OTC), prescription and hospital. Our product portfolio comprises both proprietary and in-licensed products, and includes patented, branded and generic drugs. Our business model is to develop and in-license products for sale by our own dedicated sales teams in our home markets of Australia and New Zealand and in certain Southeast Asian markets, and to out-license our products to local licensees and distributors to the rest of the world. For more information: aftpharm.com